The development of bacterial infection as an adverse effect in telaprevir-based triple therapy for chronic hepatitis C
Not Applicable
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000013562
- Lead Sponsor
- The Kyushu University Liver Disease Study
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
Positivity for antibody to human immunodeficiency virus or positivity for hepatitis B surface antigen, clinical or biochemical evidence of hepatic decompensation, hepatocellular carcinoma at entry
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method